海特生物 - Financials

海特生物 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
+Revenue	649.0M	602.0M	689.0M	615.0M	524.0M	620.0M	591.0M	750.0M	771.0M	679.0M	549.0M	356.0M
Revenue Growth %	7.8%	-12.6%	12.0%	17.4%	-15.5%	4.9%	-21.2%	-2.7%	13.5%	23.7%	54.2%	--
Total Revenue	649.0M	602.0M	689.0M	615.0M	524.0M	620.0M	591.0M	750.0M	771.0M	679.0M	549.0M	356.0M
Cost Of Revenue	371.0M	345.0M	355.0M	265.0M	214.0M	120.0M	44.2M	35.2M	35.6M	33.0M	27.1M	18.7M
+Gross Profit	278.0M	257.0M	334.0M	350.0M	310.0M	500.0M	546.8M	714.8M	735.4M	646.0M	521.9M	337.3M
Gross Margin %	42.8%	42.7%	48.5%	56.9%	59.2%	80.6%	92.5%	95.3%	95.4%	95.1%	95.1%	94.7%
Total Operating Cost	769.0M	775.0M	728.0M	615.0M	578.0M	577.0M	515.0M	603.0M	596.0M	597.0M	432.0M	266.0M
Selling Expenses	127.0M	129.0M	127.0M	146.0M	152.0M	311.0M	366.0M	496.0M	509.0M	444.0M	362.0M	219.0M
Admin Expenses	119.0M	113.0M	93.8M	97.3M	91.1M	71.2M	33.8M	21.5M	48.4M	45.8M	30.0M	20.6M
Rd Expenses	122.0M	129.0M	121.0M	103.0M	86.1M	62.6M	29.9M	24.5M	--	--	--	--
Finance Expenses	-5.1M	-7.1M	-11.2M	-12.5M	-19.8M	-11.3M	-6.8M	-8.2M	-7.2M	-1.4M	-710,400	-1.5M
+Operating Income	-75.7M	-143.0M	-6.8M	21.3M	-35.1M	75.1M	105.0M	156.0M	182.0M	94.5M	129.0M	89.8M
Operating Margin %	-11.7%	-23.8%	-1.0%	3.5%	-6.7%	12.1%	17.8%	20.8%	23.6%	13.9%	23.5%	25.2%
Non Operating Income	115,800	172,100	423,800	595,400	248,700	440,700	415,900	9.5M	2.8M	3.2M	1.0M	1.3M
Non Operating Expenses	4.5M	9.1M	1.4M	1.5M	2.5M	2.9M	608,000	127,500	616,000	481,600	1.2M	434,200
Investment Income	16.7M	15.7M	11.0M	14.3M	19.5M	34.7M	26.5M	7.7M	6.6M	12.5M	12.4M	--
Fair Value Change Income	-908,900	1.9M	12.7M	-333,200	-6.8M	-7.5M	-1.5M	--	--	--	--	--
Asset Disposal Income	-65,200	-358,700	-93,900	-181,000	-86,300	--	-14,900	2,900	-6,100	--	--	--
Asset Impairment Loss	21.1M	60.1M	33.2M	11.7M	22.0M	--	43.2M	30.2M	6.7M	73.5M	10.3M	6.4M
Other Income	28.7M	12.8M	9.2M	8.2M	5.9M	4.3M	4.0M	1.7M	--	--	--	--
Income Before Tax	-80.1M	-152.0M	-7.8M	20.5M	-37.4M	72.6M	105.0M	166.0M	184.0M	97.3M	128.0M	90.7M
Income Tax	-6.4M	-23.7M	74,200	-9.6M	-11.7M	11.4M	13.6M	24.6M	27.3M	14.0M	19.5M	13.1M
+Net Income	-73.8M	-128.0M	-7.9M	30.0M	-25.7M	61.2M	91.5M	141.0M	157.0M	83.2M	109.0M	77.6M
Net Margin %	-11.4%	-21.3%	-1.1%	4.9%	-4.9%	9.9%	15.5%	18.8%	20.4%	12.3%	19.9%	21.8%
Net Income Attributable	-69.3M	-121.0M	-14.0M	27.7M	-25.0M	63.0M	94.1M	142.0M	157.0M	83.3M	110.0M	77.7M
Minority Interest	-4.4M	-7.4M	6.1M	2.4M	-648,600	-1.8M	-2.7M	-1.2M	-318,000	-116,200	-944,400	-59,100
Eps Basic	-0.53	-0.93	-0.11	0.26	-0.24	0.61	0.91	1.65	2.03	1.09	1.59	1.21
Eps Diluted	-0.53	-0.93	-0.11	0.26	-0.24	0.61	0.91	1.65	2.03	1.09	1.59	1.21

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
Cash And Equivalents	419.0M	510.0M	748.0M	184.0M	461.0M	696.0M	307.0M	698.0M	608.0M	496.0M	472.0M	175.0M
Trading Financial Assets	450.0M	579.0M	144.0M	514.0M	250.0M	480.0M	--	--	--	--	--	--
Accounts Receivable	62.1M	52.9M	61.8M	97.8M	114.0M	203.0M	216.0M	234.0M	218.0M	174.0M	194.0M	149.0M
Notes Receivable	6.3M	8.2M	--	6.4M	2.5M	--	20.3M	32.4M	45.6M	20.4M	15.9M	9.3M
Notes And Accounts Receivable	68.5M	61.1M	61.8M	104.0M	117.0M	203.0M	237.0M	267.0M	263.0M	195.0M	210.0M	158.0M
Prepayments	4.4M	7.4M	18.2M	15.2M	7.3M	10.4M	4.2M	5.2M	4.6M	1.2M	4.9M	2.3M
Inventory	109.0M	117.0M	120.0M	71.7M	69.6M	56.6M	34.5M	22.4M	15.0M	22.2M	25.3M	25.2M
Total Current Assets	1.3B	1.5B	1.4B	1.6B	1.3B	1.5B	1.5B	1.7B	896.0M	755.0M	714.0M	364.0M
Long Term Equity Investment	11.6M	22.1M	45.4M	37.8M	--	--	--	--	--	--	--	--
Fixed Assets	--	718.0M	530.0M	480.0M	268.0M	209.0M	188.0M	98.5M	71.7M	69.5M	54.1M	51.0M
Fixed Assets Total	710.0M	718.0M	530.0M	480.0M	268.0M	209.0M	188.0M	98.5M	71.7M	69.5M	54.1M	51.0M
Construction In Progress	--	3.0M	121.0M	34.3M	80.1M	61.8M	35.0M	8.6M	26.3M	6.5M	3.5M	--
Construction In Progress Total	11.0M	3.0M	121.0M	34.3M	80.1M	61.8M	35.0M	8.6M	26.3M	6.5M	3.5M	--
Intangible Assets	253.0M	277.0M	90.4M	90.0M	95.0M	63.8M	66.1M	18.2M	18.8M	19.5M	20.3M	21.1M
Long Term Deferred Expenses	8.7M	10.2M	1.6M	2.2M	2.6M	3.3M	2.3M	--	--	--	--	--
Total Non Current Assets	1.6B	1.5B	1.3B	1.1B	858.0M	701.0M	610.0M	160.0M	143.0M	118.0M	87.3M	77.2M
Total Assets	2.9B	3.0B	2.7B	2.7B	2.2B	2.2B	2.2B	1.9B	1.0B	872.0M	801.0M	441.0M
Short Term Borrowings	7.2M	7.3M	30.0M	33.0M	6.5M	--	--	--	--	--	--	--
Accounts Payable	64.4M	52.1M	56.1M	47.8M	50.6M	27.6M	13.8M	8.0M	6.8M	5.9M	7.6M	4.4M
Advance Receipts	--	--	--	--	--	43.1M	33.7M	7.0M	15.0M	14.3M	23.7M	5.9M
Contract Liabilities	77.5M	116.0M	98.0M	66.4M	44.7M	--	--	--	--	--	--	--
Total Current Liabilities	363.0M	346.0M	285.0M	249.0M	367.0M	386.0M	431.0M	256.0M	326.0M	269.0M	262.0M	184.0M
Long Term Borrowings	11.5M	26.3M	40.9M	48.2M	--	--	--	--	--	--	--	--
Total Non Current Liabilities	162.0M	130.0M	87.0M	105.0M	94.3M	23.4M	14.6M	10.1M	10.1M	6.2M	2.9M	2.9M
Total Liabilities	525.0M	476.0M	372.0M	354.0M	462.0M	409.0M	446.0M	266.0M	336.0M	276.0M	265.0M	186.0M
Paid In Capital	131.0M	131.0M	122.0M	122.0M	103.0M	103.0M	103.0M	103.0M	77.5M	77.5M	75.9M	64.3M
Capital Reserve	1.8B	1.8B	1.6B	1.6B	988.0M	990.0M	990.0M	990.0M	218.0M	216.0M	190.0M	30.6M
Surplus Reserve	53.9M	53.3M	53.3M	53.3M	53.3M	53.3M	53.3M	53.3M	38.8M	35.6M	27.0M	15.9M
Retained Earnings	370.0M	457.0M	578.0M	592.0M	564.0M	606.0M	553.0M	490.0M	362.0M	267.0M	241.0M	142.0M
Minority Equity	19.8M	17.4M	24.8M	18.7M	16.3M	8.2M	10.0M	6.7M	6.5M	716,600	2.0M	1.5M
Equity Attributable	2.4B	2.5B	2.3B	2.3B	1.7B	1.8B	1.7B	1.6B	697.0M	596.0M	535.0M	253.0M
Total Equity	2.4B	2.5B	2.3B	2.3B	1.7B	1.8B	1.7B	1.6B	703.0M	597.0M	537.0M	255.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013
Cash From Sales	569.0M	623.0M	680.0M	547.0M	527.0M	703.0M	669.0M	759.0M	712.0M	604.0M	530.0M	240.0M
Tax Refunds Received	2.3M	33.2M	23.3M	8.0M	3.5M	--	--	--	--	--	--	--
Total Operating Cash Inflow	688.0M	682.0M	735.0M	582.0M	574.0M	715.0M	680.0M	778.0M	747.0M	649.0M	571.0M	307.0M
Cash Paid For Goods	200.0M	243.0M	273.0M	174.0M	197.0M	97.4M	22.9M	20.0M	8.3M	13.2M	14.4M	22.8M
Cash Paid To Employees	284.0M	253.0M	209.0M	173.0M	114.0M	89.5M	50.8M	39.8M	32.5M	28.8M	21.8M	17.6M
Taxes Paid	30.2M	24.0M	32.6M	28.3M	28.4M	48.1M	50.4M	52.7M	52.4M	47.9M	53.5M	33.7M
Total Operating Cash Outflow	666.0M	677.0M	682.0M	570.0M	593.0M	652.0M	607.0M	695.0M	603.0M	489.0M	435.0M	230.0M
Operating Cash Flow	22.7M	5.3M	53.0M	12.1M	-19.7M	63.0M	73.4M	83.1M	144.0M	160.0M	135.0M	76.8M
Total Investing Cash Inflow	1.9B	1.5B	1.8B	1.5B	958.0M	1.9B	1.5B	781.0M	56.6M	25.5M	12.4M	1.0M
Total Investing Cash Outflow	2.0B	2.0B	1.3B	2.5B	1.2B	1.6B	2.0B	1.6B	36.0M	140.0M	24.1M	16.2M
Investing Cash Flow	-100.0M	-492.0M	525.0M	-953.0M	-196.0M	343.0M	-439.0M	-793.0M	20.5M	-115.0M	-11.8M	-15.2M
Cash From Borrowings	--	10.0M	--	85.0M	40.0M	--	--	--	--	--	--	--
Dividends And Interest Paid	1.8M	2.2M	1.3M	62,000	17.0M	20.7M	31.2M	--	60.9M	46.3M	--	1.0M
Debt Repayments	14.6M	47.2M	6.2M	6.0M	39.0M	--	--	--	--	--	--	20.0M
Total Financing Cash Inflow	6.9M	300.0M	--	675.0M	47.8M	--	6.0M	799.0M	8.0M	28.0M	174.0M	1.6M
Total Financing Cash Outflow	20.3M	51.7M	12.3M	12.1M	56.0M	28.5M	31.2M	--	60.9M	49.0M	--	21.0M
Financing Cash Flow	-13.4M	248.0M	-12.3M	663.0M	-8.2M	-28.5M	-25.2M	799.0M	-52.9M	-21.0M	174.0M	-19.4M
Net Change In Cash	-91.0M	-238.0M	566.0M	-278.0M	-224.0M	378.0M	-391.0M	89.6M	112.0M	24.2M	297.0M	42.2M
Ending Cash Balance	419.0M	510.0M	748.0M	182.0M	460.0M	685.0M	307.0M	698.0M	608.0M	496.0M	472.0M	175.0M
Capex	43.1M	167.0M	174.0M	247.0M	114.0M	116.0M	38.7M	22.3M	22.1M	13.6M	15.6M	15.7M